GSK stock at EUR 22.41 ahead of the Xetra open: drugmaker
Published on 10/21/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and market setting
- GSK develops and sells vaccines and medicines for human health markets.
- The company’s home-market benchmark is the FTSE 100 in the United Kingdom.
- GSK stock trades pre-market at EUR 22.41 at 8:27 a.m. CEST at Lang & Schwarz on October 21, 2026.
GSK develops vaccines and medicines for human health markets. GSK stock trades pre-market at EUR 22.41 at 8:27 a.m. CEST at Lang & Schwarz on October 21, 2026.
Ahead of the Xetra open
The pre-market indication comes ahead of the Xetra session, which starts at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of GSK stock.
How GSK makes its money
GSK researches, develops and manufactures vaccines and specialty and general medicines for disease prevention and treatment, according to MarketBeat. Its portfolio includes vaccines and medicines addressing HIV, oncology, respiratory and immunology conditions, as well as infectious diseases. GSK’s investor materials cover quarterly results, regulatory announcements and a dividend calendar through its investor relations page. Market context: Market report FTSE 100.
